BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33918752)

  • 21. [Construction of FANCA mutant protein from Fanconi anemia patient and analysis of its function].
    Chen F; Zhang KJ; Zuo XL; Zeng XC
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):741-4. PubMed ID: 18457264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of non-homologous end joining does not rescue DNA repair defects in Fanconi anemia patient cells.
    Thongthip S; Conti BA; Lach FP; Smogorzewska A
    Cell Cycle; 2020 Oct; 19(19):2553-2561. PubMed ID: 32865112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of FANCA mutations in Greek patients.
    Selenti N; Sofocleous C; Kattamis A; Kolialexi A; Kitsiou S; Fryssira E; Polychronopoulou S; Kanavakis E; Mavrou A
    Anticancer Res; 2013 Aug; 33(8):3369-74. PubMed ID: 23898106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.
    Castella M; Pujol R; Callén E; Trujillo JP; Casado JA; Gille H; Lach FP; Auerbach AD; Schindler D; Benítez J; Porto B; Ferro T; Muñoz A; Sevilla J; Madero L; Cela E; Beléndez C; de Heredia CD; Olivé T; de Toledo JS; Badell I; Torrent M; Estella J; Dasí A; Rodríguez-Villa A; Gómez P; Barbot J; Tapia M; Molinés A; Figuera A; Bueren JA; Surrallés J
    Blood; 2011 Apr; 117(14):3759-69. PubMed ID: 21273304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular defects identified by whole exome sequencing in a child with Fanconi anemia.
    Zheng Z; Geng J; Yao RE; Li C; Ying D; Shen Y; Ying L; Yu Y; Fu Q
    Gene; 2013 Nov; 530(2):295-300. PubMed ID: 23973728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fanconi anemia pathway limits human papillomavirus replication.
    Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
    J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families.
    Kimble DC; Lach FP; Gregg SQ; Donovan FX; Flynn EK; Kamat A; Young A; Vemulapalli M; Thomas JW; Mullikin JC; Auerbach AD; Smogorzewska A; Chandrasekharappa SC
    Hum Mutat; 2018 Feb; 39(2):237-254. PubMed ID: 29098742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analysis of Fanconi anemia mutations in China.
    Li N; Ding L; Li B; Wang J; D'Andrea AD; Chen J
    Exp Hematol; 2018 Oct; 66():32-41.e8. PubMed ID: 30031030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
    Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
    Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells.
    Li X; Wu L; Zopp M; Kopelov S; Du W
    Stem Cells; 2019 Jul; 37(7):937-947. PubMed ID: 30977208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks.
    Chun MJ; Kim S; Hwang SK; Kim BS; Kim HG; Choi HI; Kim JH; Goh SH; Lee CH
    Oncotarget; 2016 Aug; 7(33):53642-53653. PubMed ID: 27449087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia.
    Krausz C; Riera-Escamilla A; Chianese C; Moreno-Mendoza D; Ars E; Rajmil O; Pujol R; Bogliolo M; Blanco I; Rodríguez I; Badell I; Ruiz-Castañé E; Surrallés J
    Genet Med; 2019 Jan; 21(1):189-194. PubMed ID: 29904161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies.
    Bogliolo M; Pujol R; Aza-Carmona M; Muñoz-Subirana N; Rodriguez-Santiago B; Casado JA; Rio P; Bauser C; Reina-Castillón J; Lopez-Sanchez M; Gonzalez-Quereda L; Gallano P; Catalá A; Ruiz-Llobet A; Badell I; Diaz-Heredia C; Hladun R; Senent L; Argiles B; Bergua Burgues JM; Bañez F; Arrizabalaga B; López Almaraz R; Lopez M; Figuera Á; Molinés A; Pérez de Soto I; Hernando I; Muñoz JA; Del Rosario Marin M; Balmaña J; Stjepanovic N; Carrasco E; Cuesta I; Cosuelo JM; Regueiro A; Moraleda Jimenez J; Galera-Miñarro AM; Rosiñol L; Carrió A; Beléndez-Bieler C; Escudero Soto A; Cela E; de la Mata G; Fernández-Delgado R; Garcia-Pardos MC; Sáez-Villaverde R; Barragaño M; Portugal R; Lendinez F; Hernadez I; Vagace JM; Tapia M; Nieto J; Garcia M; Gonzalez M; Vicho C; Galvez E; Valiente A; Antelo ML; Ancliff P; Garcia F; Dopazo J; Sevilla J; Paprotka T; Pérez-Jurado LA; Bueren J; Surralles J
    J Med Genet; 2020 Apr; 57(4):258-268. PubMed ID: 31586946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective cell proliferation is an attribute of overexpressed Notch1 receptor and impaired autophagy in Fanconi Anemia.
    Zipporah E B; Patra B; Govarthanan K; Yadav R; Mohan S; Shyamsunder P; Verma RS
    Genomics; 2020 Nov; 112(6):4628-4639. PubMed ID: 32800766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FANCA c.3624C>T (p.Ser1208=) is a hypomorphic splice variant associated with delayed onset of Fanconi anemia.
    Ramanagoudr-Bhojappa R; Tryon R; Lach FP; Donovan FX; Maxwell R; Rosenberg A; MacMillan ML; Wagner JE; Auerbach AD; Smogorzewska A; Chandrasekharappa SC
    Blood Adv; 2024 Feb; 8(4):899-908. PubMed ID: 38191666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and analysis of the mouse Fanconi anemia group A cDNA and an overlapping penta zinc finger cDNA.
    Wong JC; Alon N; Norga K; Kruyt FA; Youssoufian H; Buchwald M
    Genomics; 2000 Aug; 67(3):273-83. PubMed ID: 10936049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for subcomplexes in the Fanconi anemia pathway.
    Medhurst AL; Laghmani el H; Steltenpool J; Ferrer M; Fontaine C; de Groot J; Rooimans MA; Scheper RJ; Meetei AR; Wang W; Joenje H; de Winter JP
    Blood; 2006 Sep; 108(6):2072-80. PubMed ID: 16720839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.